Key Market Indicators
Norwegian vaccination coverage for children aged one is projected to rise to 99% by 2028, up from 98% in 2023. This marks an average annual increase of 0.2 percentage points. Since 1988, the country's vaccination rate has consistently grown by 0.4 percentage points each year. The nation's vaccine imports are expected to reach approximately $53 million by 2028, up from around $47 million in 2023. This represents an average annual growth rate of 1.8%. Since 1998, Norwegian demand for vaccines has increased by an average of 2.5% per year. In contrast, Norwegian vaccine exports experienced a dramatic rise in 2018, reaching $14,380, up from just $655 in 2017—a staggering increase of 2,100%. Despite this spike, the long-term trend since 1998 shows a significant decline in vaccine supply, with exports falling by an average of 67.7% each year.
